Literature DB >> 3532817

Potentiating synergism between adenosine diphosphate or triphosphate and acetylcholine on insulin secretion.

G Bertrand, J Chapal, M M Loubatieres-Mariani.   

Abstract

The interaction between adenosine di- or triphosphate (ADP or ATP) and acetylcholine (ACh) was studied on insulin secretion. The experiments were performed on the isolated perfused rat pancreas, in the presence of a physiological nonstimulating glucose concentration (5.5 mM). ADP or ATP (1.65 microM) and ACh (0.05 microM) elicited a comparable peak of insulin secretion. When either ATP or ADP was simultaneously infused with ACh, insulin secretory response was significantly higher than the sum of the responses of each agonist applied separately. Similar effects were obtained with stable structural analogues of ATP and ADP (adenylimidodiphosphate, AMP-PNP, and alpha, beta-methyleneadenosine 5'-diphosphate, alpha, beta-methylene ADP) whether they acted alone or in combination with ACh. In contrast, adenosine was ineffective. Furthermore, the study of combined half doses of ATP (or ADP) and ACh allowed us to establish a potentiating synergism between both agonists. These data indicate a potentiating synergism on the beta-cell between ACh and ATP or ADP, the substances acting, respectively, via muscarinic cholinergic receptors and purinergic P2 receptors. So, ATP and ADP by activating P2 receptors could be involved in the parasympathetic control of insulin secretion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3532817     DOI: 10.1152/ajpendo.1986.251.4.E416

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  Purinergic receptors in the endocrine and exocrine pancreas.

Authors:  I Novak
Journal:  Purinergic Signal       Date:  2007-12-11       Impact factor: 3.765

2.  Role of P2-purinergic receptors in rat Leydig cell steroidogenesis.

Authors:  C Foresta; M Rossato; A Nogara; F Gottardello; P Bordon; F Di Virgilio
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

3.  The beta-cell glibenclamide receptor is an ADP-binding protein.

Authors:  I Niki; J L Nicks; S J Ashcroft
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

4.  Evidence for two different P2-purinoceptors on beta cell and pancreatic vascular bed.

Authors:  G Bertrand; J Chapal; M M Loubatières-Mariani; M Roye
Journal:  Br J Pharmacol       Date:  1987-08       Impact factor: 8.739

5.  PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance.

Authors:  F Jamen; K Persson; G Bertrand; N Rodriguez-Henche; R Puech; J Bockaert; B Ahrén; P Brabet
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

6.  Plasticity of mouse enteric synapses mediated through endocannabinoid and purinergic signaling.

Authors:  I M Hons; M A Storr; K Mackie; B Lutz; Q J Pittman; G M Mawe; K A Sharkey
Journal:  Neurogastroenterol Motil       Date:  2012-01-11       Impact factor: 3.598

7.  Comparative effects of PACAP and VIP on pancreatic endocrine secretions and vascular resistance in rat.

Authors:  G Bertrand; R Puech; Y Maisonnasse; J Bockaert; M M Loubatières-Mariani
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

8.  Evidence for a glutamate receptor of the AMPA subtype which mediates insulin release from rat perfused pancreas.

Authors:  G Bertrand; R Gross; R Puech; M M Loubatières-Mariani; J Bockaert
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

Review 9.  Purinergic signalling in endocrine organs.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

10.  Adenosine-5'-O-(2-thiodiphosphate) is a potent agonist at P2 purinoceptors mediating insulin secretion from perfused rat pancreas.

Authors:  G Bertrand; J Chapal; R Puech; M M Loubatières-Mariani
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.